Cargando…
Structural Insight into IAPP‐Derived Amyloid Inhibitors and Their Mechanism of Action
Designed peptides derived from the islet amyloid polypeptide (IAPP) cross‐amyloid interaction surface with Aβ (termed interaction surface mimics or ISMs) have been shown to be highly potent inhibitors of Aβ amyloid self‐assembly. However, the molecular mechanism of their function is not well underst...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154662/ https://www.ncbi.nlm.nih.gov/pubmed/31863711 http://dx.doi.org/10.1002/anie.201914559 |
_version_ | 1783521866396205056 |
---|---|
author | Niu, Zheng Prade, Elke Malideli, Eleni Hille, Kathleen Jussupow, Alexander Mideksa, Yonatan G. Yan, Li‐Mei Qian, Chen Fleisch, Markus Messias, Ana C. Sarkar, Riddhiman Sattler, Michael Lamb, Don C. Feige, Matthias J. Camilloni, Carlo Kapurniotu, Aphrodite Reif, Bernd |
author_facet | Niu, Zheng Prade, Elke Malideli, Eleni Hille, Kathleen Jussupow, Alexander Mideksa, Yonatan G. Yan, Li‐Mei Qian, Chen Fleisch, Markus Messias, Ana C. Sarkar, Riddhiman Sattler, Michael Lamb, Don C. Feige, Matthias J. Camilloni, Carlo Kapurniotu, Aphrodite Reif, Bernd |
author_sort | Niu, Zheng |
collection | PubMed |
description | Designed peptides derived from the islet amyloid polypeptide (IAPP) cross‐amyloid interaction surface with Aβ (termed interaction surface mimics or ISMs) have been shown to be highly potent inhibitors of Aβ amyloid self‐assembly. However, the molecular mechanism of their function is not well understood. Using solution‐state and solid‐state NMR spectroscopy in combination with ensemble‐averaged dynamics simulations and other biophysical methods including TEM, fluorescence spectroscopy and microscopy, and DLS, we characterize ISM structural preferences and interactions. We find that the ISM peptide R3‐GI is highly dynamic, can adopt a β‐like structure, and oligomerizes into colloid‐like assemblies in a process that is reminiscent of liquid–liquid phase separation (LLPS). Our results suggest that such assemblies yield multivalent surfaces for interactions with Aβ40. Sequestration of substrates into these colloid‐like structures provides a mechanistic basis for ISM function and the design of novel potent anti‐amyloid molecules. |
format | Online Article Text |
id | pubmed-7154662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71546622020-04-14 Structural Insight into IAPP‐Derived Amyloid Inhibitors and Their Mechanism of Action Niu, Zheng Prade, Elke Malideli, Eleni Hille, Kathleen Jussupow, Alexander Mideksa, Yonatan G. Yan, Li‐Mei Qian, Chen Fleisch, Markus Messias, Ana C. Sarkar, Riddhiman Sattler, Michael Lamb, Don C. Feige, Matthias J. Camilloni, Carlo Kapurniotu, Aphrodite Reif, Bernd Angew Chem Int Ed Engl Research Articles Designed peptides derived from the islet amyloid polypeptide (IAPP) cross‐amyloid interaction surface with Aβ (termed interaction surface mimics or ISMs) have been shown to be highly potent inhibitors of Aβ amyloid self‐assembly. However, the molecular mechanism of their function is not well understood. Using solution‐state and solid‐state NMR spectroscopy in combination with ensemble‐averaged dynamics simulations and other biophysical methods including TEM, fluorescence spectroscopy and microscopy, and DLS, we characterize ISM structural preferences and interactions. We find that the ISM peptide R3‐GI is highly dynamic, can adopt a β‐like structure, and oligomerizes into colloid‐like assemblies in a process that is reminiscent of liquid–liquid phase separation (LLPS). Our results suggest that such assemblies yield multivalent surfaces for interactions with Aβ40. Sequestration of substrates into these colloid‐like structures provides a mechanistic basis for ISM function and the design of novel potent anti‐amyloid molecules. John Wiley and Sons Inc. 2020-01-28 2020-03-27 /pmc/articles/PMC7154662/ /pubmed/31863711 http://dx.doi.org/10.1002/anie.201914559 Text en © 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Niu, Zheng Prade, Elke Malideli, Eleni Hille, Kathleen Jussupow, Alexander Mideksa, Yonatan G. Yan, Li‐Mei Qian, Chen Fleisch, Markus Messias, Ana C. Sarkar, Riddhiman Sattler, Michael Lamb, Don C. Feige, Matthias J. Camilloni, Carlo Kapurniotu, Aphrodite Reif, Bernd Structural Insight into IAPP‐Derived Amyloid Inhibitors and Their Mechanism of Action |
title | Structural Insight into IAPP‐Derived Amyloid Inhibitors and Their Mechanism of Action |
title_full | Structural Insight into IAPP‐Derived Amyloid Inhibitors and Their Mechanism of Action |
title_fullStr | Structural Insight into IAPP‐Derived Amyloid Inhibitors and Their Mechanism of Action |
title_full_unstemmed | Structural Insight into IAPP‐Derived Amyloid Inhibitors and Their Mechanism of Action |
title_short | Structural Insight into IAPP‐Derived Amyloid Inhibitors and Their Mechanism of Action |
title_sort | structural insight into iapp‐derived amyloid inhibitors and their mechanism of action |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154662/ https://www.ncbi.nlm.nih.gov/pubmed/31863711 http://dx.doi.org/10.1002/anie.201914559 |
work_keys_str_mv | AT niuzheng structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT pradeelke structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT malidelieleni structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT hillekathleen structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT jussupowalexander structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT mideksayonatang structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT yanlimei structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT qianchen structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT fleischmarkus structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT messiasanac structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT sarkarriddhiman structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT sattlermichael structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT lambdonc structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT feigematthiasj structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT camillonicarlo structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT kapurniotuaphrodite structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction AT reifbernd structuralinsightintoiappderivedamyloidinhibitorsandtheirmechanismofaction |